Skip to content

Turmeric Extract and Oxidative Stress in Muaythai Athletes and Sedentary Men

Determination of Oxidative Stress Levels and Some Antioxidant Activities in Muaythai Athletes Using Turmeric Extract

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07904598
Enrollment
44
Registered
2026-10-29
Start date
2025-01-15
Completion date
2025-02-15
Last updated
2026-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Keywords

Muaythai, Turmeric Extract, Antioxidants, Malondialdehyde, Catalase, Glutathione

Brief summary

This study examined whether taking turmeric extract for 28 days affects oxidative stress and antioxidant defenses in healthy men who practice Muaythai and men who do not exercise regularly. Oxidative stress occurs when reactive molecules exceed the body's protective defenses and can damage cells. The study included 44 healthy men aged 18-25 years in four groups of 11: Muaythai athletes without supplementation, Muaythai athletes taking turmeric extract, men who did not exercise regularly and received no supplementation, and men who did not exercise regularly and took turmeric extract. Participants were first categorized as Muaythai athletes or sedentary individuals according to their physical activity status. Within each category, participants were randomly allocated to the turmeric supplementation group or the control group using a lottery method. The supplementation groups received 400 mg of turmeric extract daily for 28 days. The athlete groups followed a structured Muaythai training program. Blood samples were collected on Day 1 and Day 28 to measure malondialdehyde, a marker of oxidative stress, and catalase and reduced glutathione, which are involved in the body's antioxidant defenses. Changes over time were evaluated within and between groups.

Detailed description

To minimize the acute effects of exercise on oxidative stress and biochemical parameters, all participants underwent a three-day period of complete rest before each blood sampling session. Venous blood samples were collected at baseline (Day 1) and at the end of the intervention (Day 28).

Interventions

DIETARY_SUPPLEMENTTurmeric Extract

Participants in the Muaythai plus turmeric and sedentary plus turmeric groups received one capsule containing 400 mg of turmeric root extract (Solgar), standardized to 93% total curcuminoids (372 mg), once daily after the evening meal for 28 days.

BEHAVIORALStructured Muaythai Training

Participants in both Muaythai athlete groups followed a structured Muaythai training program based on progressive overload for 28 days.

Sponsors

Sinan Ağlar
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Four parallel groups of 11 participants each were studied: Muaythai athletes without supplementation, Muaythai athletes receiving turmeric extract, sedentary men without supplementation, and sedentary men receiving turmeric extract. Supplementation consisted of 400 mg of turmeric extract daily for 28 days. Participants remained in their respective groups throughout the study. Blood samples were collected on Days 1 and 28.

Eligibility

Sex/Gender
MALE
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men aged 18-25 years residing in Van, Türkiye. * Non-smokers and non-drinkers. * Provision of written informed consent. * For the Muaythai groups: regular Muaythai practice for at least eight years, training six days per week, and placement among the top three in a Turkish national championship or selection for the national team. * For the sedentary groups: no sports background and no regular exercise participation.

Exclusion criteria

* Failure to meet the inclusion criteria. * Allergic reactions to turmeric identified during pre-supplementation allergy screening in participants considered for the supplementation groups.

Design outcomes

Primary

MeasureTime frameDescription
Change in malondialdehyde (MDA) levelBaseline (Day 1) and Day 28Change in blood malondialdehyde (MDA) level from Day 1 to Day 28, measured spectrophotometrically and expressed in µmol/L.
Change in catalase (CAT) activityBaseline (Day 1) and Day 28Change in blood catalase (CAT) activity from Day 1 to Day 28, measured spectrophotometrically and expressed in U/mL.
Change in reduced glutathione (GSH) levelBaseline (Day 1) and Day 28Change in blood reduced glutathione (GSH) level from Day 1 to Day 28, measured spectrophotometrically and expressed in µmol/L.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 31, 2026